{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:34:29Z","timestamp":1776958469276,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACyT 20020130100826BA"],"award-info":[{"award-number":["UBACyT 20020130100826BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020130100584BA"],"award-info":[{"award-number":["20020130100584BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2331\/2013"],"award-info":[{"award-number":["PICT 2331\/2013"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["2281\/2013"],"award-info":[{"award-number":["2281\/2013"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.antiviral.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T16:21:48Z","timestamp":1439050908000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1"],"prefix":"10.1016","volume":"122","author":[{"given":"Mar\u00eda Eugenia","family":"D\u00e1vola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela I.","family":"Mazaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario D.","family":"Galigniana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Alch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier A.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea A.","family":"Barquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.08.002_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2014.03.002","article-title":"Multicomponent synthesis of 4,4-dimethyl sterol analogues and their effect on eukaryotic cells","volume":"84","author":"Alonso","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2015.08.002_b0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/QCO.0000000000000015","article-title":"Herpes simplex virus drug-resistance: new mutations and insights","volume":"26","author":"Andrei","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.002_b0015","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1128\/JVI.79.9.5863-5869.2005","article-title":"Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin","volume":"79","author":"Andrei","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.002_b0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2014.02.007","article-title":"A dihydro-pyrido-indole potently inhibits HSV-1 infection by interfering the viral immediate early transcriptional events","volume":"105","author":"Bag","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.002_b0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.steroids.2010.02.015","article-title":"D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: synthesis and biological evaluation","volume":"75","author":"Banday","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2015.08.002_b0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virusres.2008.12.013","article-title":"A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent","volume":"141","author":"Bueno","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.08.002_b0035","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2174\/092986710791163975","article-title":"Plant and animal steroids a new hope to search for antiviral agents","volume":"17","author":"Castilla","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.08.002_b0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0039-128X(99)00016-1","article-title":"Evaluation of the antiviral activity of natural sulfated polyhydroxysteroids and their synthetic derivatives and analogs","volume":"64","author":"Comin","year":"1999","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2015.08.002_b0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbrc.2012.09.019","article-title":"Sterol analogues with diamide side chains interfere with the intracellular localization of viral glycoproteins","volume":"427","author":"D\u00e1vola","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2015.08.002_b0050","doi-asserted-by":"crossref","DOI":"10.1021\/cr100233r","article-title":"Chemistry and biology of multicomponent reactions","author":"D\u00f6mling","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.antiviral.2015.08.002_b0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s13365-013-0189-3","article-title":"Immunological control of herpes simplex virus infections","volume":"19","author":"Egan","year":"2013","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2015.08.002_b0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1139\/o94-004","article-title":"Effect of tunicamycin and monensin on the transport to the cell surface and secretion of a viral membrane glycoprotein containing both N- and O-linked sugars","volume":"72","author":"Ghosh-Choudhury","year":"1994","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2015.08.002_b0065","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/521262","article-title":"Herpes simplex encephalitis in Sweden, 1990\u20132001: incidence, morbidity, and mortality","volume":"45","author":"Hjalmarsson","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.002_b0070","first-page":"1","article-title":"Chapter one \u2013 antiviral agents for herpes simplex virus","author":"Hodge","year":"2013"},{"key":"10.1016\/j.antiviral.2015.08.002_b0075","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.steroids.2011.09.006","article-title":"Pregnenolone derivatives as potential anticancer agents","volume":"76","author":"Iqbal Choudhary","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2015.08.002_b0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.steroids.2004.04.011","article-title":"In vitro and in vivo antiherpetic activity of three new synthetic brassinosteroid analogues","volume":"69","author":"Michelini","year":"2004","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2015.08.002_b0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2008.05.005","article-title":"Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives","volume":"111","author":"Michelini","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.08.002_b0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/095632020301400503","article-title":"Antiherpes virus activities of new 6\u201319 carbon-bridged steroids and some synthetic precursors","volume":"14","author":"Petrera","year":"2003","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2015.08.002_b0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.steroids.2013.10.010","article-title":"Click chemistry decoration of amino sterols as promising strategy to developed new leishmanicidal drugs","volume":"79","author":"Porta","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2015.08.002_b0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","article-title":"Herpes keratitis","volume":"32","author":"Rowe","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.antiviral.2015.08.002_b9005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/infdis\/169.4.879","article-title":"A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates","volume":"169","author":"Safrin","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.002_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2014.07.017","article-title":"Ellagitannins as synergists of ACV on the replication of ACV-resistant strains of HSV 1 and 2","volume":"110","author":"Vilhelmova-Ilieva","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.002_b0110","first-page":"72","article-title":"Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection","volume":"19","author":"Wang","year":"2014","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2015.08.002_b0115","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.tetlet.2008.01.130","article-title":"Synthesis of novel isoxazole-linked steroidal glycoconjugates-an application of a novel steroidal nitrile oxide","volume":"49","author":"Wankhede","year":"2008","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.antiviral.2015.08.002_b0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","article-title":"Privileged scaffolds for library design and drug discovery","volume":"14","author":"Welsch","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.antiviral.2015.08.002_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2006.04.002","article-title":"Herpes simplex encephalitis: adolescents and adults","volume":"71","author":"Whitley","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.08.002_b0130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.002_b0135","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/jo01038a507","article-title":"The structure proof of 16\u03b1-carboxypregnenolone","volume":"28","author":"Woroch","year":"1963","journal-title":"J. Org. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T09:50:31Z","timestamp":1537437031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":28,"alternative-id":["S0166354215001886"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.08.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}